Literature DB >> 15937465

Neutralizing antibodies take a swipe at HIV in vivo.

David C Montefiori.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15937465     DOI： 10.1038/nm0605-593

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  Neutralization of HIV-1 by redirection of natural antibodies.

Authors:  Maria F Perdomo; Michael Levi; Matti Sällberg; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

2.  Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies.

Authors:  Kyle J Nakamura; Chiara Cerini; Edwin R Sobrera; Laura Heath; Moses Sinkala; Chipepo Kankasa; Donald M Thea; James I Mullins; Louise Kuhn; Grace M Aldrovandi
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

3.  Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.

Authors:  Bruce K Brown; Nicos Karasavvas; Zoltan Beck; Gary R Matyas; Deborah L Birx; Victoria R Polonis; Carl R Alving
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.

Authors:  Aviva Joseph; Jian Hua Zheng; Ken Chen; Monica Dutta; Cindy Chen; Gabriela Stiegler; Renate Kunert; Antonia Follenzi; Harris Goldstein
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

5.  4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms.

Authors:  Kyle J Nakamura; Johannes S Gach; Laura Jones; Katherine Semrau; Jan Walter; Frederic Bibollet-Ruche; Julie M Decker; Laura Heath; William D Decker; Moses Sinkala; Chipepo Kankasa; Donald Thea; James Mullins; Louise Kuhn; Michael B Zwick; Grace M Aldrovandi
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

6.  Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Authors:  Akram A Da'dara; Donald A Harn
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

7.  Unique genotypic features of HIV-1 C gp41 membrane proximal external region variants during pregnancy relate to mother-to-child transmission via breastfeeding.

Authors:  Li Yin; Kai-Fen Chang; Kyle J Nakamura; Louise Kuhn; Grace M Aldrovandi; Maureen M Goodenow
Journal:  J Clin Pediatr Neonatol       Date:  2021

8.  Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.

Authors:  Ali Azizi; David E Anderson; Masoud Ghorbani; Katrina Gee; Francisco Diaz-Mitoma
Journal:  BMC Immunol       Date:  2006-10-31       Impact factor: 3.615

Review 9.  The antigenome: from protein subunit vaccines to antibody treatments of bacterial infections?

Authors:  Carmen Giefing; Eszter Nagy; Alexander von Gabain
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.